Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

PATTI, Angelo Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.921
EU - Europa 2.210
AS - Asia 725
AF - Africa 28
SA - Sud America 17
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 6.911
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.904
IT - Italia 1.108
CN - Cina 318
FI - Finlandia 294
SG - Singapore 275
DE - Germania 230
UA - Ucraina 138
IE - Irlanda 99
GB - Regno Unito 96
RU - Federazione Russa 53
SE - Svezia 53
FR - Francia 31
IN - India 31
RO - Romania 31
IR - Iran 26
BE - Belgio 21
CI - Costa d'Avorio 20
KR - Corea 17
HK - Hong Kong 15
CA - Canada 9
CH - Svizzera 8
ES - Italia 7
IL - Israele 7
TR - Turchia 7
NL - Olanda 6
PL - Polonia 6
GR - Grecia 5
MX - Messico 5
AT - Austria 4
CL - Cile 4
CZ - Repubblica Ceca 4
EU - Europa 4
PK - Pakistan 4
AU - Australia 3
BG - Bulgaria 3
BR - Brasile 3
DZ - Algeria 3
PH - Filippine 3
SA - Arabia Saudita 3
TW - Taiwan 3
UZ - Uzbekistan 3
VN - Vietnam 3
AR - Argentina 2
CO - Colombia 2
DK - Danimarca 2
EG - Egitto 2
ET - Etiopia 2
HU - Ungheria 2
ID - Indonesia 2
JP - Giappone 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BO - Bolivia 1
BT - Bhutan 1
BY - Bielorussia 1
CR - Costa Rica 1
EC - Ecuador 1
GE - Georgia 1
HN - Honduras 1
HT - Haiti 1
IM - Isola di Man 1
JO - Giordania 1
KE - Kenya 1
LU - Lussemburgo 1
ME - Montenegro 1
NO - Norvegia 1
NP - Nepal 1
PE - Perù 1
QA - Qatar 1
RS - Serbia 1
SM - San Marino 1
VE - Venezuela 1
Totale 6.911
Salva come PNG Salva come JPEG
Città #
Fairfield 556
Chandler 406
Ashburn 330
Wilmington 254
Woodbridge 251
Singapore 234
Seattle 216
Houston 210
Cambridge 182
Ann Arbor 164
Palermo 116
Medford 108
Des Moines 104
Dublin 98
Jacksonville 77
Princeton 68
Altamura 67
Nanjing 67
Rome 67
Milan 61
Lawrence 51
Santa Clara 44
New York 41
San Diego 37
Boardman 32
Jinan 30
Tulsa 26
Dearborn 25
Shenyang 23
Beijing 22
Nanchang 22
Changsha 21
Abidjan 20
Hebei 19
Tianjin 19
Brussels 18
Redwood City 18
Ningbo 17
London 16
Ludwigshafen am Rhein 16
Tehran 16
Florence 13
Naples 12
Verona 12
Bari 11
Napoli 11
San Paolo di Civitate 11
Columbus 10
Falls Church 10
Jiaxing 10
Munich 10
Cagliari 9
Kumar 9
Pisa 9
Seongnam 9
Venice 9
Bangalore 8
Catania 8
Chicago 8
Edinburgh 8
Guidizzolo 8
Saint Petersburg 8
Auburn Hills 7
Central 7
Haikou 7
Helsinki 7
Lappeenranta 7
Padova 7
Pune 7
Taizhou 7
Dallas 6
Genoa 6
Guangzhou 6
Gwangmyeong 6
Hong Kong 6
Izmir 6
Lanzhou 6
Phoenix 6
Piscataway 6
Zhengzhou 6
Amsterdam 5
Azor 5
Castrovillari 5
Los Angeles 5
Moscow 5
Turin 5
Washington 5
Avola 4
Bologna 4
Brescia 4
Hangzhou 4
Massarosa 4
Migliarino 4
Novara 4
Orange 4
Salerno 4
Springfield 4
Toronto 4
Agrigento 3
Alcamo 3
Totale 4.573
Salva come PNG Salva come JPEG
Nome #
PROBIOTICI E TERAPIA CONVENZIONALE: NUOVE FRONTIERE NELLA GESTIONE DELLE MANIFESTAZIONI ARTICOLARI DELLE MALATTIE INFIAMMATORIE INTESTINALI (IBD) 750
Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: A 6 months prospective study 194
Elevated blood Hsp60, its structural similarities and cross-reactivity with thyroid molecules, and its presence on the plasma membrane of oncocytes point to the chaperonin as an immunopathogenic factor in Hashimoto's thyroiditis 166
Management of Statin Intolerance in 2018: Still More Questions Than Answers 158
Osteodystrophy in chronic liver diseases. 155
Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study 151
The effect of bergamot on dyslipidemia 150
Effects of Chitosan on Plasma Lipids and Lipoproteins: A 4-Month Prospective Pilot Study 149
Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study 144
Autoimmune liver disease in a sicilian woman. 140
Liraglutide increases serum levels of microRNA27b,-130a and-210 in patients with type 2 diabetes mellitus: A novel epigenetic effect 138
The Role of Nutraceuticals in Statin Intolerant Patients 137
Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study. 132
Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome 130
IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins 125
O- Alkylation of a lignite humic acid by phase-transfer catalysis 119
Cloni di carciofo "Romanesco" in coltura annuale in Sicilia 116
Lichen sclerosus as a cause of recurrent cystitis: case report and review of the literatury. 115
Effects of hypolipidemic and hypoglycemic agents on atherogenic small, dense LDL in Type 2 diabetes 115
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: An 18-month prospective study 115
Diagnostica non invasiva delle varici esofagee nei pazienti con cirrosi epatica: dati ecografici vs dati endoscopici 114
REPORT OF A CASE OF MALIGNANT TUMOR-LIKE GASTRIC LESION BY CANDIDA IN A DIABETIC TREATED WITH CYCLOSPORINE FOR PSORIASIS AND REVIEW OF THE LITERATURE 114
Liraglutide improves carotid intima-media thickness in patients with type-2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study 114
Daily use of extra virgin olive oil with high oleocanthal concentration reduced body weight, waist circumference, alanine transaminase, inflammatory cytokines and hepatic steatosis in subjects with the metabolic syndrome: A 2-month intervention study 105
MALIGNANT TUMOR-LIKE GAASTRIC LESION DUE TO CANDIDA ALBICANS IN A DIABETIC PATIENT TREATED WITH CYCLOSPORIN: A CASE REPORT AND REVIEW OF THE LITERATURE 103
Cilostazol and atherogenic dyslipidemia: a clinically relevant effect 103
The effects of liraglutide on glucose, inflammatory markers and lipoprotein metabolism: current knowledge and future perspectives. 102
Smoking and small, dense low-density lipoproteins. 98
Pasta Supplemented with Opuntia ficus-indica Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study 97
INCRETIN-BASED THERAPIES, GLUCOMETABOLIC HEALTH AND ENDOVASCULAR INFLAMMATION 96
Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: An 8-month prospective pilot study 94
Malignant tumor-like gastric lesion by Candida albicans. 92
GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms 92
Food hypersensitivity in patients with irritable bowel syndrome: the diagnostic role of fecal assays. 91
Gli effetti extraglicemici di liraglutide: Focus sui marker cardiometabolici 91
Improving diagnostic accuracy in Celiac Disease diagnosis: anti-endomysium antibody assay in colture medium of duodenal biopsies. 90
Anti-atherogenic Effects of 17β-Estradiol 90
Clinical anatomic, immunomorphologic and molecular anatomic data suggest interplay of thyroidal molecules, autoantibodies and Hsp60 in Hashimoto’s disease 84
Nutraceuticals as an important part of combination therapy in dyslipidaemia 84
Food hypersensitivity-associated irritable bowel syndrome: may fecal assays improve diagnosis? 82
Effects of Liraglutide on Metabolic Parameters and Carotid Intima-Media Thickness in Patients with The Metabolic Syndrome: A 12-Month Prospective Pilot Study 82
The efficacy and safety of dipeptidyl peptidase-4 inhibitors compared to other oral glucose-lowering medications in the treatment of type 2 diabetes 82
Variazioni emodinamiche del circolo epatico in pazienti con bright liver ecopattern e sindrome metabolica 81
Effects of Liraglutide on Carotid Intima-Media Thickness in Patients with Type-2 Diabetes and Non-Alcoholic Fatty Liver Disease: An 8-Month Prospective Pilot Study 80
Metabolic disorders during pregnancy and postpartum cardiometabolic risk 79
Improving diagnostic accuracy in celiac disease diagnosis: antiendomysium antibody assay in the culture medium of duodenal biopsies. 76
Advances in pharmacological treatment of type 1 diabetes during pregnancy 76
Lichen sclerosus and atrophicus: report of a case of female patient affected with recurrent cystitis. 75
Rare Candida albicans overgrowth in an immunosuppressed patient: case report of a malignant tumor-like gastric lesion. 73
Future perspectives of the pharmacological management of diabetic dyslipidemia 73
Prevalence of antibodies anti-bartonella henselae in western Sicily: children, blood donors, cats 71
Serological, immunomorphological and bioinformatics analyses suggest Hsp60 is involved in Hashimoto’s thyroiditis pathogenesis. 71
Effect of liraglutide on carotid intima-media thickness in patients with type-2 diabetes: a 4-month prospective study 71
Effects of liraglutide on plasma ghrelin concentrations and oxidative stress in patients with type 2 diabetes: a 2-month prospective pilot study. 68
Natural approaches in metabolic syndrome management 67
Prediction of vascular events in subjects with subclinical atherosclerosis and the metabolic syndrome: the role of markers of inflammation. 64
Polyphenols: Potential use in the prevention and treatment of cardiovascular diseases 61
Pharmacotherapy for gestational diabetes 58
Nutraceuticals in Lipid-Lowering Treatment: A Narrative Review on the Role of Chitosan 54
Pharmacotherapy for gestational diabetes mellitus: still insulin, or what about sulfonylureas? 53
A novel beneficial effect of liraglutide: the reduction in subclinical atherosclerosis in patients with type-2 diabetes. 52
Prediction of vascular events in subjects with subclinical atherosclerosis and the metabolic syndrome: the role of markers of inflammation. 49
Oxidative stress and small, dense low-density lipoproteins: Current and future perspectives 49
PREVALENCE OF LIVER STEATOSIS AND FIBROSIS AND RELIABILITY OF ULTRASOUND IN DETECTING NAFLD IN OBESE PATIENTS 45
Novel therapeutical approaches to managing atherosclerotic risk 44
A Nutraceutical Containing Chlorogenic Acid and Luteolin Improves Cardiometabolic Parameters in Subjects with Pre-Obesity: A 6-Month Randomized, Double-Blind, Placebo-Controlled Study 43
Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect 33
NUOVE STRATEGIE PER IL MANAGEMENT CLINICO, DIAGNOSTICO E TERAPEUTICO DELLE MALATTIE CARDIO-METABOLICHE 31
An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes 29
Novel molecular markers of cardiovascular disease risk in type 2 diabetes mellitus 29
Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study 25
Experimental and Emerging Free Fatty Acid Receptor Agonists for the Treatment of Type 2 Diabetes 24
Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes 21
Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies 20
Obesity and HFpEF 14
Genetic and Epigenetic Biomarkers For Diagnosis, Prognosis and Treatment Of Metabolic Syndrome 14
The role of atherogenic lipoproteins in diabetes: Molecular aspects and clinical significance 12
Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 Diabetes 10
Advances in the Pharmacological Management of Diabetic Nephropathy: A 2022 International Update 10
Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i): Current Evidence for Expanding the Paradigm? 10
Evaluating the Impact of Novel Incretin Therapies on Cardiovascular Outcomes in Type 2 Diabetes: An Early Systematic Review. 6
Totale 7.320
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.043
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.043
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020787 0 0 0 0 103 146 109 78 120 56 140 35
2020/20211.196 25 63 106 243 171 42 62 90 109 130 68 87
2021/2022881 51 136 40 32 23 38 35 76 92 140 66 152
2022/20231.411 135 211 30 135 126 191 126 120 151 37 91 58
2023/2024681 35 91 53 43 44 143 85 37 20 18 34 78
2024/2025516 29 172 113 143 59 0 0 0 0 0 0 0
Totale 7.320